These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 18975359

  • 1. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, Grimm A, Devore MD, Wingrove C, Zhang L.
    Arthritis Rheum; 2008 Nov 15; 59(11):1639-46. PubMed ID: 18975359
    [Abstract] [Full Text] [Related]

  • 2. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.
    Kozora E, Ellison MC, West S.
    Arthritis Rheum; 2006 Aug 15; 55(4):628-35. PubMed ID: 16874786
    [Abstract] [Full Text] [Related]

  • 3. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.
    Filley CM, Kozora E, Brown MS, Miller DE, West SG, Arciniegas DB, Grimm A, Zhang L.
    Cogn Behav Neurol; 2009 Mar 15; 22(1):38-44. PubMed ID: 19372769
    [Abstract] [Full Text] [Related]

  • 4. Do subjective cognitive complaints correlate with cognitive impairment in systemic lupus erythematosus? A Danish outpatient study.
    Vogel A, Bhattacharya S, Larsen JL, Jacobsen S.
    Lupus; 2011 Jan 15; 20(1):35-43. PubMed ID: 21233148
    [Abstract] [Full Text] [Related]

  • 5. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimäki T, Peltola J, Korpela M, Heinonen T, Nikkari ST.
    Arthritis Rheum; 2004 Mar 15; 50(3):858-65. PubMed ID: 15022328
    [Abstract] [Full Text] [Related]

  • 6. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations.
    Kozora E, Filley CM, Zhang L, Brown MS, Miller DE, Arciniegas DB, Pelzman JL, West SG.
    Lupus; 2012 Apr 15; 21(4):402-11. PubMed ID: 22170761
    [Abstract] [Full Text] [Related]

  • 7. Cognitive function in a systemic lupus erythematosus inception cohort.
    Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, Holliday SL, Padilla PA, Brey RL.
    J Rheumatol; 2008 Sep 15; 35(9):1776-81. PubMed ID: 18634154
    [Abstract] [Full Text] [Related]

  • 8. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus.
    Glanz BI, Slonim D, Urowitz MB, Gladman DD, Gough J, MacKinnon A.
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct 15; 10(4):232-8. PubMed ID: 9359119
    [Abstract] [Full Text] [Related]

  • 9. Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression?
    Cavaco S, Martins da Silva A, Santos E, Coutinho E, Marinho A, Moreira I, Gonçalves A, Pinto C, Teixeira-Pinto A, Vasconcelos C.
    J Rheumatol; 2012 Apr 15; 39(4):770-6. PubMed ID: 22382338
    [Abstract] [Full Text] [Related]

  • 10. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.
    Emmer BJ, Steup-Beekman GM, Steens SC, Huizinga TW, van Buchem MA, van der Grond J.
    Arthritis Rheum; 2008 May 15; 58(5):1451-7. PubMed ID: 18438847
    [Abstract] [Full Text] [Related]

  • 11. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP, Rood MJ, Zwinderman AH, Huizinga TW, van Buchem MA.
    Arthritis Rheum; 2000 Jan 15; 43(1):48-54. PubMed ID: 10643699
    [Abstract] [Full Text] [Related]

  • 12. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
    Roebuck-Spencer TM, Yarboro C, Nowak M, Takada K, Jacobs G, Lapteva L, Weickert T, Volpe B, Diamond B, Illei G, Bleiberg J.
    Arthritis Rheum; 2006 Jun 15; 55(3):434-41. PubMed ID: 16739211
    [Abstract] [Full Text] [Related]

  • 13. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P, Annese V, D'agostini S, Venturini P, La Torre G, De Vita S, Ferraccioli GF.
    Arthritis Rheum; 2007 Dec 15; 57(8):1461-72. PubMed ID: 18050188
    [Abstract] [Full Text] [Related]

  • 14. Cognitive dysfunction in systemic lupus erythematosus.
    Emori A, Matsushima E, Aihara O, Ohta K, Koike R, Miyasaka N, Kato M.
    Psychiatry Clin Neurosci; 2005 Oct 15; 59(5):584-9. PubMed ID: 16194262
    [Abstract] [Full Text] [Related]

  • 15. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA.
    J Rheumatol; 2005 Aug 15; 32(8):1459-6. PubMed ID: 16078320
    [Abstract] [Full Text] [Related]

  • 16. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study.
    Appenzeller S, Cendes F, Costallat LT.
    Arthritis Rheum; 2009 May 15; 61(5):680-7. PubMed ID: 19405004
    [Abstract] [Full Text] [Related]

  • 17. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T, Hirata D, Onda K, Nara H, Minota S.
    J Rheumatol; 2005 Jan 15; 32(1):34-9. PubMed ID: 15630721
    [Abstract] [Full Text] [Related]

  • 18. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
    Hanly JG, Robichaud J, Fisk JD.
    J Rheumatol; 2006 Aug 15; 33(8):1553-8. PubMed ID: 16881112
    [Abstract] [Full Text] [Related]

  • 19. Cognitive impairment in patients with systemic lupus erythematosus.
    Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B.
    J Rheumatol; 1992 Apr 15; 19(4):562-7. PubMed ID: 1593578
    [Abstract] [Full Text] [Related]

  • 20. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul 15; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.